Print Issue: October 01, 2007

Lowering Homocysteine Not Beneficial

Using high doses of folic acid and B vitamins to lower elevated homocysteine levels in patients with advanced CKD (ACKD) or end-stage renal disease (ESRD) does not improve survival or decrease the incidence of vascular disease, data show.

Immunosuppression To Fit the Patient

Researchers have identified a gene signature that may enable clinicians to distinguish which renal transplant recipients could be eligible for a progressive decrease in their immunosuppressive medications and who needs to stay on their current dose.

How to Manage Vitamin D Deficiency

The active forms of vitamin D—calcitriol, paricalcitol, and doxercalciferol—which also are known as vitamin D receptor activators (VDRAs), have been largely used in nephrology only as a treatment for secondary hyperparathyroidism, an elevation in parathyroid hormone (PTH) due to renal failure.

Next post in Expert Reviews